We believe that there is a significant opportunity to help improve mental health and wellbeing for millions of people globally
Psyence is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing.
Our vision is that our enduring work expands access to mental wellness and nurtures community. We will achieve this by developing and providing innovative, safe and effective psychedelic and nature-centred solutions for mental health and palliative care.
Psyence is developing proprietary natural psilocybin drug development and treatment protocols with a focus on palliative care
The current treatments available for adjustment disorder associated with a terminal diagnosis are lacking. While antidepressant medication can be effective it can also diminish quality of life. Research has shown that natural psilocybin drugs are safe and effective and allow for a better quality of life.
Our natural psilocybin mushrooms
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa. This product is produced for export to our partners across the world to be processed into a standardised encapsulated product.
We believe that the growing consumer demand for nature-based medicine and plant-based products, may incentivise the use of natural psilocybin as a therapeutic agent. The psilocybin molecule from natural sources is the same as synthetically derived products. However, the natural sourced product has other similar acting molecules to psilocybin, which may have synergistic and desirable effects.
Our natural psilocybin mushrooms
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa. This product is produced for export to our partners across the world to be processed into a standardised encapsulated product.
We believe that the growing consumer demand for nature-based medicine and plant-based products, may incentivise the use of natural psilocybin as a therapeutic agent. The psilocybin molecule from natural sources is the same as synthetically derived products. However, the natural sourced product has other similar acting molecules to psilocybin, which may have synergistic and desirable effects.
Our Team
Jody Aufrichtig
Co-Founder, Executive Chairman and Director
Tony Budden
Chief Strategy Officer
Neil Van Rij
Mycologist
Taryn Vos
General Counsel
Warwick Corden-Lloyd
Non Executive Director
Alan Friedman
Capital Markets Advisor and Director
Mary-Elizabeth Gifford
EVP for Public Policy & Global Impact
